Specific targeting of tumor cells by the creatine analog cyclocreatine

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 993-999

  Martin, Katherine J ^a,c   Winslow, Elizabeth R ^a   O'Keefe, Margaret ^a,b   Khandekar, Vrinda S ^a   Hamlin Jr , Allen ^a   Lillie, James W ^a,d   Kaddurah Daouk, Rima ^a,b  

^a Amira Corporation   (United States)

^b Avicena Group Inc   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

anticancer drug; creatine kinase; cyclocreatine

Indexed keywords

CREATINE KINASE; CYCLOCREATINE;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029963496     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.993     Document Type: Article

References (27)

1. Kaddurah-Daouk R, Lillie JW, Daouk GH, Green MR, Kingston R and Schimmel P: Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a. Mol Cell Biol 10: 1476-1483, 1990.
2. Martin KJ, Chen SF, Clark GM, Degen D, Wajima M, Von Hoff DD and Kaddurah-Daouk R: Evaluation of creatine analogs as a new class of anticancer agents using freshly explanted human tumor cells. J Natl Cancer Inst 86: 608-613, 1994.
3. Gazda AF, Zweig MH, Carney DN, Van Steirteghen AC, Baylin SB and Minna JD: Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res 41: 2773-2777, 1981.
4. Ishiguro Y, Kato K, Akatsuka H and Ito T: The diagnostic and prognostic value of pretreatment serum creatine kinase BB levels in patients with neuroblastoma. Cancer 65: 2014-2019, 1990.
5. Binderman I, Harel S, Earon Y, Tomer A, Weisman Y, Kaye AM and Somjen D: Acute stimulation of creatine kinase activity by vitamin D metabolites in the developing cerebellum. Biochim Biophys Acta 972: 9-16, 1988.
6. Reiss NA and Kaye AM: Identification of the major component of estrogen-induced protein of rat uterus as the BB isozyme of creatine kinase. J Biol Chem 256: 23-26, 1981.
7. Somjen D, Weisman Y, Harell A, Berger E and Kaye AM: Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA 86: 3361-3365, 1989.
8. Somjen D, Zor U, Kaye AM, Harell A and Binderman I: Parathyroid hormone induction of creatine kinase activity and DNA synthesis is mimicked by phospholipase C, diacylglycerol and phorbol ester. Biochim Biophys Acta 931: 215-223, 1987.
9. Chida K, Tsuneaga M, Kasahara K, Kohno Y and Kuroki T: Regulation of creatine phosphokinase B activity by protein kinase C. Biochem Biophys Res Commun 173: 346-350, 1990.
10. Chida K, Kasahara K, Tsuneaga M, Kohno Y, Yamada S, Ohmi S and Kuroki T: Purification and identification of creatine phosphokinase B as a substrate of protein kinase C in mouse skin in vivo. Biochem Biophys Res Commun 173: 351-357, 1990.
11. Zhao J, Schmeig FI, Simmons DT and Molloy GR: Mouse p53 represses the rat brain creatine kinase gene but inactivates the rat muscle creatine kinase gene. Mol Cell Biol 14: 8483-8492, 1994.
12. Wallimann T, Wyss M, Brdiczka D, Nicolay K and Eppenberger HM: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 281: 21-40, 1992.
13. Lillie JW, O'Keefe M, Valinski H, Hamlin A, Varban ML and Kaddurah-Daouk R: Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res 53: 1-7, 1993.
14. Miller EE, Evans AE and Cohn M: Inhibition of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 90: 3304-3308, 1993.
15. Teicher BA, Menon K, Northey D, Liu J, Kufe DW and Kaddurah-Daouk, R: Cyclocreatine in cancer chemotherapy. Cancer Chemoth Pharmacol 35: 411-416, 1995.
16. Walker JB: Creatine: biosynthesis, regulation, and function. Adv Enzymol 50: 177-241, 1979.
17. Martin KJ, Vassallo CV, Teicher BA and Kaddurah-Daouk R: Microtubule stabilization and potentiation of taxol activity by a creatine analog. Anti-Cancer Drugs 6: 419-426, 1995.
18. Annesley TM and Walker JB: Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energetic considerations. Biochem Biophys Res Commun 74: 185-190, 1977.
19. Schimmel L, Khandekar VS, Martin KJ, Riera T, Honan C, Shaw DG and Kaddurah-Daouk R: The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors. Anticancer Res 16: 375-380, 1996.
20. Bergnes G, Yuan W, Khandekar VS, Martin KJ, Teicher BA, and Kaddurah-Daouk R: Creatine and phosphocreatine analogs: Anticancer activity and enzymatic analysis. Oncol Res 8: 121-130, 1996.
21. Griffiths GR and Walker JB: Accumulation of analog of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). J Biol Chem 251: 2049-2054, 1976.
22. Bradford MM: A rapid and sensitive method for the quantitiation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
23. Beis I and Newsholme EA: The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles for vertebrates and invertebrates. Biochem J 152: 23-32, 1975.
24. Yaffe D and Saxel O: Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727, 1977.
25. Shatton JB, Morris HP and Weinhouse S: Creatine kinase activity and isozyme composition in normal tissues and neoplasms of rats and mice. Cancer Res 39: 492-501, 1979.
26. Tsung SH: Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin Chem 22: 173-175, 1976.
27. 31P nuclear magnetic resonance evaluation of intact heart. Cardiology 80: 184-195, 1992.